These two treatments reach different tissue, in different ways, for different reasons. Ultherapy focuses ultrasound through intact skin to a point beneath it. RF microneedling puts needles through the skin and releases radiofrequency from the needle tips.
Ultherapy is the one with real cosmetic wording behind it. It was authorised through a De Novo, DEN080006, granted 11 September 2009, which created its FDA device category. Its current indications read: "lift the eyebrow," "lift lax submental (beneath the chin) and neck tissue," and "improve lines and wrinkles of the decollete." A February 2025 clearance added skin laxity on the abdomen and the front and back of the arms.
Most RF microneedling clearances name no cosmetic use at all. They read "intended for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis" — surgical language for sealing tissue and stopping bleeding, which names no cosmetic use. Morpheus8 added "coagulation or contraction of soft tissue" in 2023. A few devices are exceptions: Vivace and Virtue RF carry a facial wrinkle indication at 1 MHz, Profound carries facial wrinkles and, on its SubQ handpiece, improvement in the appearance of cellulite in Fitzpatrick I to III.
The practical trade-off is the wound. Ultherapy leaves no break in the skin, so there is no infection route and no visible healing. RF microneedling makes thousands of small channels, which is what allows it to work on texture and scarring, and is also why it costs you a few days.
It is the only device here with real-time ultrasound imaging, so the operator can see the tissue layer before firing.
The brands differ in needle count, depth range, frequency and insulation.
At the focus, tissue reaches coagulation temperature and forms small columns of denatured collagen. Everything above the focus is spared.
The heating is electrical, so it does not depend on skin pigment.
The 4.5 mm depth reaches the SMAS, the fibrous layer surgeons lift in a facelift.
Exceptions exist. Vivace and Virtue RF name facial wrinkles at 1 MHz. Profound names facial wrinkles and, on its SubQ handpiece, the appearance of cellulite in Fitzpatrick I to III.
It does not treat surface texture, pores or scarring, because nothing reaches the epidermis.
Acne scarring is the best-evidenced use: a 2025 systematic review covered 16 studies and 481 patients, including six randomised trials.
Skin barrier measurements peak on days one to three and return to baseline by day seven.
In a study of stretch marks, RF microneedling was rated significantly more painful than fractional CO2 — mean pain scores of 5.35 versus 2.35 on the same scale.
Ask what you want changed.
Many people want both, and there is no published trial that tells you how to sequence them.
Six months is where the evidence runs out for RF microneedling. The longest properly measured follow-up in the published literature is six months after the final treatment. A critical review of 42 higher-quality studies concluded that the collagen remodelling is "slow and progressive" and continues to improve to six months. That is a statement about six months, not about years.
Clinic copy that promises one to three years has no published source behind it. Neither treatment stops ageing, and no study has separated a fading result from continued ageing.
If you get cold sores, say so when you book RF microneedling, not on the day. Antiviral medication is started in advance. No study has measured cold-sore reactivation after RF microneedling; the precaution comes from laser resurfacing, where it is well documented.
Tell either provider about a pacemaker or implantable defibrillator. For radiofrequency devices this is a labelled contraindication, and the right person to advise you is your cardiology team.